Fatty acid oxidation disorders

Piero Rinaldo, Dietrich Matern, Michael J. Bennett

Research output: Contribution to journalArticle

281 Citations (Scopus)

Abstract

Genetic disorders of mitochondrial fatty acid β-oxidation have been recognized within the last 20 years as important causes of morbidity and mortality, highlighting the physiological significance of fatty acids as an energy source. Although the mammalian mitochondrial fatty acid-oxidizing system was recognized at the beginning of the last century, our understanding of its exact nature remains incomplete, and new components are being identified frequently. Originally described as a four-step enzymatic process located exclusively in the mitochondrial matrix, we now recognize that long-chain-specific enzymes are bound to the inner mitochondrial membrane, and some enzymes are expressed in a tissue-specific manner. Much of our new knowledge of fatty acid metabolism has come from the study of patients who were diagnosed with single-gene autosomal recessive defects, a situation that seems to be further evolving with the emergence of phenotypes determined by combinations of multiple genetic and environmental factors. This review addresses the normal process of mitochondrial fatty acid β-oxidation and discusses the clinical, metabolic, and molecular aspects of more than 20 known inherited diseases of this pathway that have been described to date.

Original languageEnglish (US)
Pages (from-to)477-502
Number of pages26
JournalAnnual Review of Physiology
Volume64
DOIs
StatePublished - 2002

Fingerprint

Fatty Acids
Recessive Genes
Inborn Genetic Diseases
Mitochondrial Membranes
Enzymes
Morbidity
Phenotype
Mortality

Keywords

  • Carnitine
  • Inborn errors
  • Ketogenesis
  • Membrane transport
  • Tissue specificity

ASJC Scopus subject areas

  • Physiology

Cite this

Fatty acid oxidation disorders. / Rinaldo, Piero; Matern, Dietrich; Bennett, Michael J.

In: Annual Review of Physiology, Vol. 64, 2002, p. 477-502.

Research output: Contribution to journalArticle

Rinaldo, Piero ; Matern, Dietrich ; Bennett, Michael J. / Fatty acid oxidation disorders. In: Annual Review of Physiology. 2002 ; Vol. 64. pp. 477-502.
@article{01c257eb09164c6cb26504abc5a1011a,
title = "Fatty acid oxidation disorders",
abstract = "Genetic disorders of mitochondrial fatty acid β-oxidation have been recognized within the last 20 years as important causes of morbidity and mortality, highlighting the physiological significance of fatty acids as an energy source. Although the mammalian mitochondrial fatty acid-oxidizing system was recognized at the beginning of the last century, our understanding of its exact nature remains incomplete, and new components are being identified frequently. Originally described as a four-step enzymatic process located exclusively in the mitochondrial matrix, we now recognize that long-chain-specific enzymes are bound to the inner mitochondrial membrane, and some enzymes are expressed in a tissue-specific manner. Much of our new knowledge of fatty acid metabolism has come from the study of patients who were diagnosed with single-gene autosomal recessive defects, a situation that seems to be further evolving with the emergence of phenotypes determined by combinations of multiple genetic and environmental factors. This review addresses the normal process of mitochondrial fatty acid β-oxidation and discusses the clinical, metabolic, and molecular aspects of more than 20 known inherited diseases of this pathway that have been described to date.",
keywords = "Carnitine, Inborn errors, Ketogenesis, Membrane transport, Tissue specificity",
author = "Piero Rinaldo and Dietrich Matern and Bennett, {Michael J.}",
year = "2002",
doi = "10.1146/annurev.physiol.64.082201.154705",
language = "English (US)",
volume = "64",
pages = "477--502",
journal = "Annual Review of Physiology",
issn = "0066-4278",
publisher = "Annual Reviews Inc.",

}

TY - JOUR

T1 - Fatty acid oxidation disorders

AU - Rinaldo, Piero

AU - Matern, Dietrich

AU - Bennett, Michael J.

PY - 2002

Y1 - 2002

N2 - Genetic disorders of mitochondrial fatty acid β-oxidation have been recognized within the last 20 years as important causes of morbidity and mortality, highlighting the physiological significance of fatty acids as an energy source. Although the mammalian mitochondrial fatty acid-oxidizing system was recognized at the beginning of the last century, our understanding of its exact nature remains incomplete, and new components are being identified frequently. Originally described as a four-step enzymatic process located exclusively in the mitochondrial matrix, we now recognize that long-chain-specific enzymes are bound to the inner mitochondrial membrane, and some enzymes are expressed in a tissue-specific manner. Much of our new knowledge of fatty acid metabolism has come from the study of patients who were diagnosed with single-gene autosomal recessive defects, a situation that seems to be further evolving with the emergence of phenotypes determined by combinations of multiple genetic and environmental factors. This review addresses the normal process of mitochondrial fatty acid β-oxidation and discusses the clinical, metabolic, and molecular aspects of more than 20 known inherited diseases of this pathway that have been described to date.

AB - Genetic disorders of mitochondrial fatty acid β-oxidation have been recognized within the last 20 years as important causes of morbidity and mortality, highlighting the physiological significance of fatty acids as an energy source. Although the mammalian mitochondrial fatty acid-oxidizing system was recognized at the beginning of the last century, our understanding of its exact nature remains incomplete, and new components are being identified frequently. Originally described as a four-step enzymatic process located exclusively in the mitochondrial matrix, we now recognize that long-chain-specific enzymes are bound to the inner mitochondrial membrane, and some enzymes are expressed in a tissue-specific manner. Much of our new knowledge of fatty acid metabolism has come from the study of patients who were diagnosed with single-gene autosomal recessive defects, a situation that seems to be further evolving with the emergence of phenotypes determined by combinations of multiple genetic and environmental factors. This review addresses the normal process of mitochondrial fatty acid β-oxidation and discusses the clinical, metabolic, and molecular aspects of more than 20 known inherited diseases of this pathway that have been described to date.

KW - Carnitine

KW - Inborn errors

KW - Ketogenesis

KW - Membrane transport

KW - Tissue specificity

UR - http://www.scopus.com/inward/record.url?scp=0036197207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036197207&partnerID=8YFLogxK

U2 - 10.1146/annurev.physiol.64.082201.154705

DO - 10.1146/annurev.physiol.64.082201.154705

M3 - Article

VL - 64

SP - 477

EP - 502

JO - Annual Review of Physiology

JF - Annual Review of Physiology

SN - 0066-4278

ER -